Map Pharmaceuticals Appoints New Vice President

Map Pharmaceuticals (Map) has appointed Alan Petro as a vice president of manufacturing and technical operations. Mr Petro will be responsible for product/process development and manufacturing in order to prepare for the commercialisation of the company’s lead product candidate, Levadex orally inhaled migraine therapy. Mr Petro will report to Timothy Nelson, president and CEO of Map.

Mr Petro brings to the company more than 25 years of product/process development and manufacturing operations experience within the healthcare industry. Most recently, Mr Petro was the vice president of supply chain management for Carl Zeiss Meditec where he was responsible for both internal manufacturing and external vendor supply, as well as procurement.

The company said that Mr Petro has also implemented lean manufacturing methods and developed a strategic sourcing business model. Previously, he held positions with senior and executive level responsibilities in product engineering, supply chain, manufacturing and regulatory affairs at Siemens Medical Solutions and General Electric Medical Systems.

Timothy Nelson, president and CEO of Map, said: “Al’s ability to oversee clinical and commercial scale product development processes, as well as his experience in implementing manufacturing infrastructures that meet regulatory and commercial needs make him an ideal addition to our team as we move towards our goal of commercialising Levadex.”